GuidelineJournal of Korean medical science2014
Practical guidelines for the surgical treatment of gallbladder cancer.
Guideline in Journal of Korean medical science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.
- Postoperative prognostic factors in patients with T2 gallbladder cancer: a meta-analysis.World journal of surgical oncology · 2025Pooled it
- Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis.Langenbeck's archives of surgery · 2020Pooled it
- Per Protocol Analysis and Long-Term Outcomes of Laparoscopic Radical Resection for Gallbladder Cancer Compared With Open Method.World journal of surgery · 2026Article
- Optimal timing of reoperation for postoperatively diagnosed T2 gallbladder cancer: a retrospective multicenter cohort study.Hepatobiliary surgery and nutrition · 2026Article
- Real-World Application of a Machine Learning-Based Early Recurrence Model for Guiding Adjuvant Chemotherapy Use in Patients with Gallbladder Cancer.Gut and liver · 2026Article
- Robotic single-port plus one-port radical cholecystectomy: description of surgical techniques with video.Journal of minimally invasive surgery · 2026Article
- Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy.Materials today. Bio · 2026Article
- Gallbladder Adenocarcinoma With Metastasis in a Young Patient Without Traditional Risk Factors.Cureus · 2026Article
- Review
- Extended versus simple cholecystectomy in stage I gallbladder cancer: a SEER-based competing risk analysis with external validation.World journal of surgical oncology · 2025Article
- Laparoscopic Reoperation for Postoperatively Diagnosed Gallbladder Cancer: Technical Options for Cystic Duct Management.Annals of surgical oncology · 2025Article
- Risk Factors and Prognostic Factors in GBC.Journal of clinical medicine · 2024Review
- Incidental gallbladder cancer detected during laparoscopic cholecystectomy: conversion to extensive resection is a feasible choice.Frontiers in surgery · 2024Article
- Oncologic safety of robotic extended cholecystectomy for gallbladder cancer.Surgical endoscopy · 2023Article
- Effect of different surgical options on the long-term survival of stage I gallbladder cancer: a retrospective study based on SEER database and Chinese Multi-institutional Registry.Journal of cancer research and clinical oncology · 2023Article
- Small Cell Carcinoma of the Gallbladder.Cureus · 2023Article
- Clinicopathological Significance of Cell Adhesion Molecule 4 Expression in Gallbladder Cancer and Its Prognostic Role.International journal of molecular sciences · 2023Article
- CEP55 as a promising biomarker and therapeutic target on gallbladder cancer.Frontiers in oncology · 2023Article
- Short- and long-term outcomes of laparoscopicWorld journal of gastrointestinal surgery · 2022Article
- Gallbladder cancer.Nature reviews. Disease primers · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 10 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
At present, surgical treatment is the only curative option for gallbladder (GB) cancer. Many efforts therefore have been made to improve resectability and the survival rate. However, GB cancer has a low incidence, and no randomized, controlled trials have been conducted to establish the optimal treatment modalities. The present guidelines include recent recommendations based on current understanding and highlight controversial issues that require further research. For T1a GB cancer, the optimal treatment modality is simple cholecystectomy, which can be carried out as either a laparotomy or a laparoscopic surgery. For T1b GB cancer, either simple or an extended cholecystectomy is appropriate. An extended cholecystectomy is generally recommended for patients with GB cancer at stage T2 or above. In extended cholecystectomy, a wedge resection of the GB bed or a segmentectomy IVb/V can be performed and the optimal extent of lymph node dissection should include the cystic duct lymph node, the common bile duct lymph node, the lymph nodes around the hepatoduodenal ligament (the hepatic artery and portal vein lymph nodes), and the posterior superior pancreaticoduodenal lymph node. Depending on patient status and disease severity, surgeons may decide to perform palliative surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.